Acrylamide and advanced glycation end products (AGEs) synergistically increase oxidative stress and inflammation through glutathione depletion and RAGE receptor activation, leading to accelerated development of neurodegenerative, metabolic, and cardiovascular diseases.

When acrylamide and AGEs enter the body, acrylamide uses up the main antioxidant called glutathione, which leaves cells defenseless. This lets AGEs bind to RAGE receptors on cells, which turns on a signal that makes more harmful molecules and inflammation. The lack of glutathione makes this signal stronger, and the inflammation and harmful molecules create more AGEs and make acrylamide more toxic, creating a cycle that damages nerves, blood vessels, and metabolism.